Hayden FG - Search Results

1

The immunogenicity of influenza virus vaccine in solid organ transplant recipients.

Blumberg EA, Albano C, Pruett T, Isaacs R, Fitzpatrick J, Bergin J, Crump C, Hayden FG. Blumberg EA, et al. Among authors: hayden fg. Clin Infect Dis. 1996 Feb;22(2):295-302. doi: 10.1093/clinids/22.2.295. Clin Infect Dis. 1996. PMID: 8838186

2

Safety of influenza vaccine in heart transplant recipients.

Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC. Blumberg EA, et al. Among authors: hayden fg. J Heart Lung Transplant. 1998 Nov;17(11):1075-80. J Heart Lung Transplant. 1998. PMID: 9855446 Clinical Trial.

3

Influenza A virus--induced acute otitis media.

Buchman CA, Doyle WJ, Skoner DP, Post JC, Alper CM, Seroky JT, Anderson K, Preston RA, Hayden FG, Fireman P, et al. Buchman CA, et al. Among authors: hayden fg. J Infect Dis. 1995 Nov;172(5):1348-51. doi: 10.1093/infdis/172.5.1348. J Infect Dis. 1995. PMID: 7594675

4

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.

Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M. Belshe RB, et al. Among authors: hayden fg. J Infect Dis. 2000 Mar;181(3):1133-7. doi: 10.1086/315323. J Infect Dis. 2000. PMID: 10720541 Clinical Trial.

5

In vitro selection of human rhinovirus relatively resistant to soluble intercellular adhesion molecule-1.

Arruda E, Crump CE, Hayden FG. Arruda E, et al. Among authors: hayden fg. Antimicrob Agents Chemother. 1994 Jan;38(1):66-70. doi: 10.1128/AAC.38.1.66. Antimicrob Agents Chemother. 1994. PMID: 8141582 Free PMC article.

6

Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus.

Doyle WJ, Skoner DP, Alper CM, Allen G, Moody SA, Seroky JT, Hayden FG. Doyle WJ, et al. Among authors: hayden fg. J Infect Dis. 1998 May;177(5):1260-5. doi: 10.1086/515294. J Infect Dis. 1998. PMID: 9593010 Clinical Trial.

7

In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.

Kaiser L, Crump CE, Hayden FG. Kaiser L, et al. Among authors: hayden fg. Antiviral Res. 2000 Sep;47(3):215-20. doi: 10.1016/s0166-3542(00)00106-6. Antiviral Res. 2000. PMID: 10974374

8

Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule.

Crump CE, Arruda E, Hayden FG. Crump CE, et al. Among authors: hayden fg. Antimicrob Agents Chemother. 1994 Jun;38(6):1425-7. doi: 10.1128/AAC.38.6.1425. Antimicrob Agents Chemother. 1994. PMID: 7916558 Free PMC article.

9

Comparative susceptibilities of human embryonic fibroblasts and HeLa cells for isolation of human rhinoviruses.

Arruda E, Crump CE, Rollins BS, Ohlin A, Hayden FG. Arruda E, et al. Among authors: hayden fg. J Clin Microbiol. 1996 May;34(5):1277-9. doi: 10.1128/jcm.34.5.1277-1279.1996. J Clin Microbiol. 1996. PMID: 8727918 Free PMC article.

10

Nasal and otologic effects of experimental influenza A virus infection.

Doyle WJ, Skoner DP, Hayden F, Buchman CA, Seroky JT, Fireman P. Doyle WJ, et al. Ann Otol Rhinol Laryngol. 1994 Jan;103(1):59-69. doi: 10.1177/000348949410300111. Ann Otol Rhinol Laryngol. 1994. PMID: 8291861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page